Date | Investors | Amount | Round |
---|---|---|---|
* | $4.0m | Seed | |
Total Funding | 000k |
Related Content
PhnyX Lab is at the forefront of transforming the pharmaceutical industry by offering a comprehensive discovery platform known as Cheiron. This platform is designed to streamline operations within the pharma sector by integrating both internal and external data sources. By doing so, it provides a unified view that helps pharmaceutical companies turn operational chaos into clarity. The primary clientele includes pharmaceutical companies seeking to enhance their workflow efficiency and data management capabilities. Operating within the pharmaceutical market, PhnyX Lab's business model revolves around providing a subscription-based service for access to its platform. Revenue is generated through these subscriptions, which offer clients the tools needed to optimize their data handling and decision-making processes. The platform's ability to consolidate diverse data sets into a single, coherent system is a key differentiator, enabling clients to make informed decisions swiftly and effectively.
Keywords: pharmaceutical, discovery platform, data integration, workflow efficiency, subscription-based, pharma operations, data management, decision-making, internal data, external data